Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders

• Status: Withdrawn
• Trial end date: 2016-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Depressed patients unremitted after monotherapy with citalopram or bupropion will remit following six weeks treatment with the combination of citalopram and bupropion.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: New York State Psychiatric Institute
• Treatments: Bupropion; Citalopram; Dexetimide

Criteria

Inclusion Criteria:

• non-remission in Protocol #6559R

• age 18-66

• signs informed consent

• physically healthy

Exclusion Criteria:

• bipolar disorder

• history of psychosis

• history of anorexia nervosa or bulimia

• history of seizure disorder, significant brain trauma or other medical reason to suspect increased seizure risk